PS-341 (Bortezomib), a proteasome inhibitor, has been approved for the treatment of multiple myeloma. Our previous work has shown that PS-341 induces death receptor 5 (DR5)-dependent apoptosis and enhances the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human non-small cell lung cancer (NSCLC) cells. However, the definite mechanism remains undefined. In the present study, we reveal PKCδ and RSK2 mediate PS-341-induced DR5 up-regulation involving of co-activation of Endoplasmic Reticulum Stress (ER Stress). We discovered that PS-341 activated ER stress through elevating the expression of BiP, p-eIF2α, IRE1α, ATF4, ATF3 and CHOP. Further study showed that DR5 up-regulation was dependent on ATF4, ATF3, CHOP expression. Silencing anyone of ATF4, ATF3 and CHOP expression decreased DR5 up-regulation and subsequent apoptosis. We determined that ATF4 regulated ATF3 and CHOP expression, thereafter ATF3 and CHOP formed a complex and regulated DR5 expression. In addition, we discovered that the phosphorylation of ERK1/2 and RSK2 were elevated after PS-341 treatment and inhibition of their phosphorylation using MEK1/2 inhibitor decreased DR5 level, indicating that ERK/RSK2 signaling is involved in DR5 up-regulation. Furthermore, we detected the cleavage of PKCδ, and the blockage of PKCδ expression cut down DR5 up-regulation and apoptosis. Importantly, knockdown of PKCδ expression decreased the induction of ER stress and the phosphorylation of ERK1/2 and RSK2, suggesting that PKCδ regulates DR5 expression through ERK/RSK2 signaling and ATF4-CHOP/ATF3 axis. Collectively, we show that PS-341 induces PKCδ-dependent DR5 expression through activation of ERK/RSK2 and ER Stress signaling pathway.
Introduction
Death receptor 5 (DR5, also named Apo2), one of TRAIL receptors, belongs to the tumor necrosis factor (TNF) receptor superfamily (1) . It locates to the cell surface, and becomes trimerized on binding to its ligand TRAIL and recruits adapter proteins such as Fas-associated death domain (FADD) and then forms the death inducing signaling complex (DISC), eventually activates caspase cascades (1) . Nowadays, many studies have demonstrated that inducing the expression of DR5 contributes to certain cancer therapeutic agents-induced apoptosis and enhances TRAIL-induced apoptotic pathway (1) .
CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP), a downstream component of Endoplasmic Reticulum stress pathways, can be mediated by pancreatic ER kinase (PKR)-like ER kinase (PERK)-, activating transcription factor 6 (ATF6)-and inositol-requiring enzyme 1α
(IRE1α)-induced signal transduction pathways (2, 3) . Many studies have documented that CHOP were grown in monolayer culture in RPMI 1640 with 5% fetal bovine serum (FBS) at 37℃ in a humidified atmosphere consisting of 5% CO2 and 95% air.
Western Blot Analysis
The preparation of whole cell protein lysates and the western blot processes were described previously (19) .
Silencing of Gene Expression Using Small Interfering RNA
The siRNA duplexes for control, ATF4, ATF3 and CHOP genes were described previously (11) .
PKCδ siRNA duplexes target the sequence of 5'-AAGGCTACAAATGCAGGCAAT-3'. The siRNAs were synthesized by GenePharma (Shanghai, China). HighPerfect Transfection Reagent (Qiagen) was used to transfect siRNAs into cells following the manufacture's protocol. Gene silencing effects were evaluated by western blot analysis.
Plasmid Construction
CHOP and ATF3 coding regions were amplified by PCR from HCT116 genomic DNA using the The procedures of plasmid constructions were described previously (20) , and the resultant constructs were named pLenti-CHOP and pLenti-ATF3 respectively. H157 cells were seeded in 10cm dishes and transfected with pLenti-CHOP and pLenti-ATF3 plasmids using X-tremeGENE HP DNA Transfection Reagent (Roche) following the manufacture's protocol. Then cells were harvested and subjected to immunoprecipitation with CHOP antibody (Santa Cruz Biotechnology Inc, sc-7351). The procedures of immunoprecipitation were described previously (21).
Plasmid Transient Transfection and Immunoprecipitation

Apoptosis assays
Apoptosis was evaluated by Annexin V-PE/7-AAD apoptosis detection kit purchased from BD Biosciences (San Jose, CA) following the manufacture's protocol. Caspase activation was detected by Western blotting.
Results
CHOP contributes to PS-341-induced DR5 up-regulation and apoptosis
Studies have revealed that some anti-tumor agents can up-regulate CHOP expression to induce cell apoptosis (4) (5) (6) . Consistently, we found PS-341 strongly promoted CHOP expression in NSCLC cells in a dose-dependent fashion (Fig. 1B) . In the time course assay, we detected CHOP expression occurred at 4 h, reached a peak at 12 h (H460 and H157 cells) or 24 h (Calu-1 cells) (Fig. 1B) . Besides, we noticed that CHOP expression was always earlier than DR5 up-regulation (Fig. 1B) , so we questioned whether CHOP would play an important role in PS-341-induced DR5 up-regulation. We used siRNA to silence CHOP expression and found that PS-341-induced DR5 levels were dramatically decreased (Fig. 1C) . Moreover, we examined weaker cleavage of caspase8, caspase9, caspase3 and PARP in CHOP knockdown cells after exposure to PS-341 (Fig.   1C) . Consistently, the early apoptosis was detected in CHOP siRNA-transfected cells by Annexin V staining-flow cytometry (Fig. 1D ). Taken together, we conclude that CHOP expression contributes to PS-341-induced DR5 up-regulation and apoptosis.
PS-341 activates ER stress
Because CHOP is the key member of ER stress (2, 3), we wondered whether PS-341 could activate ER stress in human NSCLC cells. We examined the expression of ATF4, ATF3, BiP, p-eIF2α and IRE1α, which are regarded as key protein markers of ER stress and found their expression were all elevated in a dose-dependent (Fig. S1A ) and a time-dependent manner ( Fig.   S1B ), indicating PS-341 activates ER stress. Studies have shown that p53 regulates ATF3 expression (22), but we found that the levels of ATF3 were increased in all tested cells no matter the p53 status (Fig. S1 ), indicating that PS-341-induced ATF3 expression is p53-independent.
ATF3 expression is required for PS-341-induced apoptosis
Since PS-341 up-regulated ATF3 expression (Fig. S1 ), we then questioned whether ATF3 had an effect on DR5 induction and apoptosis. Western blot analysis showed that the levels of DR5 and the cleaved forms of caspase8, caspase9, caspase3 and PARP were all decreased in ATF3 siRNA-transfected cells ( Fig. 2A) . By Annexin V staining-flow cytometry, the percentage of apoptotic cells in control siRNA-transfected cells was 41%, while only 26% in ATF3 siRNA-transfected cells (Fig. 2B ). So we come to a conclusion that ATF3 expression is important for PS-341-induced DR5 up-regulation and apoptosis. It is known that ATF4 could enhance CHOP expression (2, 3), so we explored whether PS-341-induced ATF4 up-regulation would contribute to DR5 expression. To do this, we successfully blocked PS-341-induced ATF4 expression using ATF4 siRNA in H460, A549 and H157 cells (Fig. 3A) . We found that the inhibition of ATF4 up-regulation decreased the expression of DR5 and CHOP and the cleavage of caspase8, caspase9, caspase3 and PARP after exposed to PS-341 (Fig. 3A) . Besides, we noticed that after abrogating ATF4 expression, PS-341-induced ATF3 expression was also reduced (Fig. 3A) . Accordingly, the percentage of apoptotic cells decreased from 29% to 19% (Fig. 3B) . Collectively, these results indicate that ATF4 expression contributes to DR5 up-regulation and is involved in PS-341-mediated apoptosis.
The relationship among ATF4, ATF3 and CHOP
We have shown that ATF4, ATF3 and CHOP were all contributed to DR5 expression, but the relationship among them is not clarified. In our experiments, we showed that ATF4 expression stimulated CHOP and ATF3 expression, as their expression was reduced in ATF4-inhibited cells (Fig. 3A) . Then we considered the relationship between CHOP and ATF3. In H157 and Calu-1 cells, when ATF3 expression was suppressed, CHOP expression was weakly inhibited while ATF4 expression was unaltered (Fig. 4A) ; when CHOP was knocked down, we detected the lightly depressed level in ATF3 expression while ATF4 was unaffected ( and detected ATF3 by Western Blot analysis. We found that ATF3 was associated with CHOP ( Fig.   4C ). Taken together, we speculate that PS-341 treatment induces ATF4 up-regulation and subsequently as a transcriptional factor, promotes ATF3 and CHOP expression. While ATF3 and CHOP form a complex, and perhaps they together regulate DR5 expression since DR5 promoter contains a functional CHOP binding site (4, 23).
ERK/RSK2 regulates DR5 expression in PS-341-induced apoptosis
Given that ERK/RSK2 signaling promotes apoptotic induction in some experiments (23, 24) , we further addressed their roles in cells exposed to PS-341. Along with the increased dose and time, the phosphorylation of ERK1/2 and RSK2 was all augmented ( Fig. 5A and 5B). When using MEK inhibitor U0126 to suppress p-ERK and p-RSK2 phosphorylation, we found that DR5 induction was diminished (Fig. 5C ), indicating that ERK/RSK2 contributes to PS-341-mediated DR5 expression.
PKCδ contributes to PS-341-induced DR5 expression and apoptosis
Since PKCδ is conducive to apoptosis, we investigated the expression of PKCδ in PS-341 treated cells. Using western blot analysis, the 41kDa fragment of PKCδ was detected in all tested cells and the levels were increased along with the enhanced concentration and time (Fig. 6A) , suggesting PS-341 activates PKCδ. Then we explored the role of PKCδ on DR5 expression when cells were exposed to PS-341. After inhibiting of PKCδ expression by small interfering RNA, we found that DR5 expression was decreased (Fig. 6B) , suggesting PKCδ contributes to DR5 induction. Furthermore, we found the cleaved forms of caspase8, caspase9, caspase3 and PARP were all reduced (Fig. 6C) , and the percentage of apoptotic cells decreased from 41% to 23% ( 6D). Therefore, we concluded that PKCδ conducted a markedly function in PS-341-mediated apoptosis. In the meantime, we noted that the phosphorylation of ERK1/2 and RSK2 in PKCδ siRNA-transfected cells was also suppressed (Fig. 6B) , suggesting that PKCδ regulates DR5 expression maybe through ERK/RSK2 signaling. Additionally, we studied the effect of PKCδ on ER stress. Compared to cells expressing PKCδ, the expression of ATF4, ATF3, CHOP were all attenuated in PKCδ abolished cells (Fig. 6B) , manifesting that the regulation of PKCδ on DR5 expression is through ER stress pathway. Taken together, we speculate that PKCδ regulates DR5 expression and apoptosis via co-activation of ERK/RSK2 signaling and subsequent ER stress.
Discussion
PS-341 has shown to induce apoptosis in various kinds of cancer cells, but the molecular mechanism is not very clear (17, 18) . Our previous studies have shown that DR5 contributes to PS-341-mediated apoptosis in human NSCLC cells (18) . In this study, we further show that PKCδ regulates DR5 expression through ERK/RSK2 signaling and ATF4-CHOP/ATF3 axis.
First, PS-341 induced CHOP up-regulation and CHOP was required for DR5 expression. Second, PS-341 activated ER stress, and both ATF3 and ATF4 contributed to DR5 induction and apoptotic sensitivity to PS-341. Third, p-ERK and p-RSK2 expression were enhanced by PS-341, and ERK/RSK2 signaling was conducive to DR5 induction. Finally, PS-341 cleaved PKCδ and PKCδ regulated DR5 expression through ERK/RSK2 signaling and ER stress.
Studies have shown that ATF4 facilitates DR5 expression in sorafenib and salermide-mediated cell death (11, 25) . Consistently, we discovered that abolished ATF4 expression effectively cut down DR5 up-regulation and the cleavage of caspase8, caspase9, caspase3 and PARP, and the (Fig. 3) . Obviously, ATF4 is a key component of DR5 induction and apoptosis. Data have shown that ATF3 plays a dichotomous role in regulating gene transcription, apoptosis and cell cycle (26) . In our experiments, silenced ATF3 expression decreased the apoptosis induced by PS-341, and the levels of DR5 were lower in ATF3-inhibited cells (Fig. 2) . This was also agreed with our previous finding that ATF3 exerts positive function in salermide-induced DR5 expression and apoptosis (11) .
Su has demonstrated that ATF4 interacts with CHOP in vivo by yeast two-hybrid screen and immunoprecipitation (27). Wang has shown that ATF3 can also form complex with ATF4 in vivo (28). Since our results showed that ATF4, ATF3 and CHOP were all contributed to DR5 expression, we examined the relationship among ATF4, ATF3 and CHOP in PS-341-induced DR5 up-regulation in NSCLC cells. In the present study we found that ATF3 and CHOP were the downstream of ATF4 (Fig. 3A) . However, ATF3 and CHOP minimally modulated each other ( Fig.   4A and 4B ). By immunoprecipitation, we found that ATF3 and CHOP had physically interaction with each other in vivo (Fig. 4C) , which also agreed with Hai that ATF3 and CHOP can form a heterodimer (9). Our and others' studies have shown that DR5 promoter contains the CHOP binding site (4, 23, 29), so we presume that ATF3 regulates DR5 expression through interaction with CHOP directly. Since ATF4 can interact with ATF3 and CHOP respectively, whether ATF4, ATF3 and CHOP form a complex to guide DR5 expression is not clear.
PKCδ can be cleaved by caspase3 and generates a catalytic fragment which is necessary for apoptosis (14) (15) (16) . In the present study, we determined that PS-341 induced the cleavage of PKCδ in a dose-and time-dependent pattern (Fig. 6A) , suggesting that PKCδ was activated by PS-341.
Work of others has determined that PKCδ causes the activation of death receptor ligands and activates the extrinsic apoptotic pathway (30). Studies also show that PKCδ contributes to ursodeoxycholic acid-induced DR5 expression in human gastric cancer cells (31). In the present study, we showed inhibition of PKCδ resulted in the decrement of DR5 expression (Fig. 6B) , proving DR5 induction is dependent on PKCδ in lung cancer cells. Furthermore, PKCδ knockdown decreased the apoptosis induced by PS-341 ( Fig. 6C and 6D ), indicating that PKCδ functions as a pro-apoptotic protein in PS-341-induced apoptosis.
Some data show that PKCδ contributes to ER stress induction, inhibited PKCδ expression decreases thapsigargin-induced CHOP expression (32). Consistenly, we detected that the up-regulation of ATF4, ATF3, CHOP were markedly suppressed in PKCδ siRNA-transfected cells (Fig. 6B) , suggesting that PKCδ is the upstream of ER stress. Then we inferred that PKCδ regulated DR5 expression relying on ER stress activation. In addition, we found that the phosphorylation of ERK1/2 and RSK2 were decreased when PKCδ expression was inhibited ( In summary, we showed that PS-341 activates PKCδ and thereafter regulates ERK/RSK2 pathway and ER stress which contributes to DR5 induction via ATF4-ATF3/CHOP axis in human NSCLC cells.
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